1. Home
  2. CTMX vs OFLX Comparison

CTMX vs OFLX Comparison

Compare CTMX & OFLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • OFLX
  • Stock Information
  • Founded
  • CTMX 2008
  • OFLX 1975
  • Country
  • CTMX United States
  • OFLX United States
  • Employees
  • CTMX N/A
  • OFLX N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • OFLX Industrial Specialties
  • Sector
  • CTMX Health Care
  • OFLX Industrials
  • Exchange
  • CTMX Nasdaq
  • OFLX Nasdaq
  • Market Cap
  • CTMX 380.9M
  • OFLX 344.9M
  • IPO Year
  • CTMX 2015
  • OFLX 2005
  • Fundamental
  • Price
  • CTMX $1.91
  • OFLX $32.87
  • Analyst Decision
  • CTMX Strong Buy
  • OFLX
  • Analyst Count
  • CTMX 3
  • OFLX 0
  • Target Price
  • CTMX $5.67
  • OFLX N/A
  • AVG Volume (30 Days)
  • CTMX 3.1M
  • OFLX 24.9K
  • Earning Date
  • CTMX 08-07-2025
  • OFLX 07-30-2025
  • Dividend Yield
  • CTMX N/A
  • OFLX 4.14%
  • EPS Growth
  • CTMX 263.20
  • OFLX N/A
  • EPS
  • CTMX 0.49
  • OFLX 1.69
  • Revenue
  • CTMX $141,100,000.00
  • OFLX $100,700,000.00
  • Revenue This Year
  • CTMX N/A
  • OFLX N/A
  • Revenue Next Year
  • CTMX N/A
  • OFLX N/A
  • P/E Ratio
  • CTMX $3.91
  • OFLX $19.49
  • Revenue Growth
  • CTMX 18.01
  • OFLX N/A
  • 52 Week Low
  • CTMX $0.40
  • OFLX $28.12
  • 52 Week High
  • CTMX $3.10
  • OFLX $57.81
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 39.81
  • OFLX 48.20
  • Support Level
  • CTMX $1.72
  • OFLX $31.45
  • Resistance Level
  • CTMX $2.43
  • OFLX $34.44
  • Average True Range (ATR)
  • CTMX 0.20
  • OFLX 1.56
  • MACD
  • CTMX -0.06
  • OFLX 0.09
  • Stochastic Oscillator
  • CTMX 26.84
  • OFLX 65.03

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About OFLX Omega Flex Inc.

Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.

Share on Social Networks: